Roche

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Roche and other ETFs, options, and stocks.

About RHHBY

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. 

CEO
Thomas Schinecker
CEOThomas Schinecker
Employees
112,774
Employees112,774
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1896
Founded1896
Employees
112,774
Employees112,774

RHHBY Key Statistics

Market cap
383.14B
Market cap383.14B
Price-Earnings ratio
23.76
Price-Earnings ratio23.76
Dividend yield
1.72%
Dividend yield1.72%
Average volume
2.45M
Average volume2.45M
High today
$58.60
High today$58.60
Low today
$57.33
Low today$57.33
Open price
$57.37
Open price$57.37
Volume
272.88K
Volume272.88K
52 Week high
$60.85
52 Week high$60.85
52 Week low
$39.50
52 Week low$39.50

RHHBY News

Simply Wall St 2d
Roche Stock Looks Undervalued As US Manufacturing Expansion Continues - simplywall.st

...

Roche Stock Looks Undervalued As US Manufacturing Expansion Continues - simplywall.st
TipRanks 4d
Roche’s Genentech announces $750M manufacturing expansion in Hillsboro, GA

Genentech, a member of the Roche (RHHBY) Group, announced plans to invest approximately $750M in a new device fill-finish manufacturing facility at its 75-acre...

Analyst ratings

48%

of 23 ratings
Buy
47.8%
Hold
43.5%
Sell
8.7%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.